Apyx Medical Reports Q1 Loss, Tops Revenue Estimates
Apyx Medical (NASDAQ: APYX) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.10 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -22.22%. A quarter ago, it was expected that this medical device maker would post a loss of $0.13 per share when it actually produced a loss of $0.19, delivering a surprise of -46.15%.
Over the last four quarters, the company has surpassed consensus EPS estimates just once.
Apyx, which belongs to the Zacks Medical – Products industry, posted revenues of $10.24 million for the quarter ended March 2024, surpassing the Zacks Consensus Estimate by 6.27%. This compares to year-ago revenues of $12.14 million. The company has topped consensus revenue estimates two times over the last four quarters.
The sustainability of the stock’s immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management’s commentary on the earnings call.
Apyx …
Full story available on Benzinga.com